conclusion:
  outcome: 18 months
  explanation: In the given case, the patient has stage II rectal adenocarcinoma with moderately differentiated differentiation histology, metastasis, and no signs of carcinomatosis. Comparing this case to the provided examples, the patient's cancer stage is lower than those in the examples, and the differentiation histology is moderately differentiated, which is generally associated with a better prognosis than poorly differentiated tumors. Under an optimal standard of care treatment plan, which may include surgery, chemotherapy, and radiation therapy, the patient is expected to have a longer progression-free survival than the patients in the examples. Considering these factors, an estimated progression-free survival of 18 months is inferred.